Skip to main content
Clinical Trials/DRKS00033812
DRKS00033812
Not yet recruiting
未知

Effect of unilateral conductive hearing loss and its therapy on neuronal activity of the auditory sys-tem – a PET, MRI/DMI, fNIRS and microphenomenologic study

niklinik Freiburg0 sites160 target enrollmentMarch 5, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
H90.1
Sponsor
niklinik Freiburg
Enrollment
160
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 5, 2024
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niklinik Freiburg

Eligibility Criteria

Inclusion Criteria

  • Study group 1:
  • \- Diagnosis with unilateral conductive hearing loss
  • \- Treatment with a bone\-conductive device or an active middle ear implant
  • Study group 2:
  • \- Diagnosis with unilateral conductive hearing loss
  • \- No treatment with a bone\-conductive device or an active middle ear implant
  • Study group 1 and 2:
  • \- age \= 18 years
  • \- right handed
  • \- German at at least B1 level

Exclusion Criteria

  • \- Relevant neurological or psychiatric illness
  • \- Circumstances and illnesses that suggest insufficient compliance with the PET or fMRI examination
  • \- Pregnancy, breastfeeding
  • \- Poorly controlled diabetes mellitus
  • \- Study\-related radiation exposure from previous study participation
  • \- Relevant ophthalmological diseases
  • \- Participants do not agree to the communication of incidental findings.

Outcomes

Primary Outcomes

Not specified

Similar Trials